These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8958590)

  • 1. HIV protease and the pathogenesis of AIDS.
    Goldberg B; Stricker RB
    Res Virol; 1996; 147(6):375-9. PubMed ID: 8958590
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
    Voshavar C
    Curr Top Med Chem; 2019; 19(18):1571-1598. PubMed ID: 31237209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in HIV protease inhibitor therapy.
    Molla A; Granneman GR; Sun E; Kempf DJ
    Antiviral Res; 1998 Jul; 39(1):1-23. PubMed ID: 9754946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors].
    Gröschel B; Spielhofen A; Stürmer M; Cinatl J; Doerr HW
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1249-54. PubMed ID: 11687987
    [No Abstract]   [Full Text] [Related]  

  • 5. The daunting challenge of keeping HIV suppressed.
    Cohen J
    Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
    [No Abstract]   [Full Text] [Related]  

  • 6. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of HIV-1 protease.
    Meek TD
    J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV protease inhibitors.
    Winslow DL; Otto MJ
    AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting the HIV-protease in AIDS therapy: a current clinical perspective.
    Tomasselli AG; Heinrikson RL
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):189-214. PubMed ID: 10708858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province].
    Yang K; Li JY; Bao ZY; Li HP; Li L; Zhuang DM; Wang Z; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):351-5. PubMed ID: 16053762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-1 evolution under pressure of protease inhibitors: climbing the stairs of viral fitness.
    Berkhout B
    J Biomed Sci; 1999; 6(5):298-305. PubMed ID: 10494036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients.
    De Milito A; Catucci M; Venturi G; Romano L; Incandela L; Valensin PE; Zazzi M
    J Med Virol; 1999 Feb; 57(2):140-4. PubMed ID: 9892398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular bases for the anti-HIV-1 effect of NO. Commentary.
    Persichini T; Ascenzi P; Colizzi V; Fraziano M; Venturini G; Colasanti M
    Int J Mol Med; 1999 Oct; 4(4):365-8. PubMed ID: 10493976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive inhibitors of the HIV-1 protease.
    Ohtaka H; Freire E
    Prog Biophys Mol Biol; 2005 Jun; 88(2):193-208. PubMed ID: 15572155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefits of resistance assay for HIV-specific protease inhibitors: when to check and in whom?
    Aizawa S; Gatanaga H; Ida S; Sakai A; Tanaka M; Takahashi Y; Hirabayashi Y; Oka S
    AIDS; 1999 Jul; 13(10):1278-9. PubMed ID: 10416536
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System.
    Mahdi M; Szojka Z; Mótyán JA; Tőzsér J
    Viruses; 2015 Nov; 7(12):6152-62. PubMed ID: 26633459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast two-hybrid assay for examining human immunodeficiency virus protease heterodimer formation with dominant-negative inhibitors and multidrug-resistant variants.
    Todd S; Laboissière MC; Craik CS
    Anal Biochem; 2000 Jan; 277(2):247-53. PubMed ID: 10625514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.